News

Examining Ulta Beauty's Upcoming Earnings and Market Outlook

Examining Ulta Beauty's Upcoming Earnings and Market Outlook

Ulta Beauty's Earnings Expectations

Ulta Beauty (NASDAQ: ULTA) is gearing up for its quarterly earnings release. Investors are eager to see how the company performs and what guidance it will provide for the upcoming quarter.

What Analysts Are Predicting

The consensus among analysts is that Ulta Beauty will report earnings per share (EPS) of $4.58. Investors are not only looking for good results but also positive future guidance to assess the company's trajectory.

Past Performance Review

Analyzing Previous Earnings Reports

In its previous financial release, Ulta Beauty exceeded EPS expectations and managed to beat estimates by $0.76. Interestingly, despite this achievement, the stock experienced a drop of 7.14% in the following trading session, showcasing the volatile nature of market reactions.

Quarterly Performance Insights

The following is a summary of Ulta Beauty's recent performance compared to estimates:

  • Q2 2025: Estimated EPS 5.02, Actual EPS 5.78, Price change % -7.00.
  • Q1 2025: Estimated EPS 5.8, Actual EPS 6.7, Price change % 12.0.
  • Q4 2024: Estimated EPS 7.15, Actual EPS 8.46, Price change % 14.00.
  • Q3 2024: Estimated EPS 4.52, Actual EPS 5.14, Price change % 9.00.

Stock Market Performance of Ulta Beauty

Current Stock Price Analysis

As of the latest data, shares of Ulta Beauty are trading at $548.05. During the past year, the stock has shown impressive resilience, climbing 40.05%. This positive trend has likely bolstered confidence among long-term investors ahead of the earnings release.

Market Sentiment Among Analysts

Staying informed about analyst opinions is crucial for investors. Currently, Ulta Beauty holds an Outperform rating based on insights from seven analysts, with a one-year price target averaging $589.86, indicating a potential upside of 7.63%.

How Does Ulta Compare to Its Peers?

Relative Performance Overview

When comparing Ulta Beauty with its industry peers, the landscape looks promising. Companies like Tractor Supply, Dick's Sporting Goods, and Chewy also enjoy favorable ratings:

  • Tractor Supply holds an Outperform rating with a year-end target of $65.36, suggesting significant growth potential.
  • Dick's Sporting Goods also enjoys an Outperform status with an expected target of $254.00.
  • Chewy is similarly rated, showing potential for considerable upside with a target of $46.56.

Peer Analysis Snapshot

The peer analysis of relevant players reveals insights into their market positioning:

CompanyConsensusRevenue GrowthGross ProfitReturn on Equity
Ulta BeautyOutperform9.26%$1.09B10.36%
Tractor SupplyOutperform7.23%$1.39B10.24%
Dick's Sporting GoodsOutperform14.29%$1.35B1.69%
ChewyOutperform8.59%$942.20M16.20%

Key takeaway: Ulta Beauty leads the pack for Revenue Growth and Gross Profit, although it ranks in the middle for Return on Equity compared to peers.

Overview of Ulta Beauty

Ulta Beauty stands as the largest beauty retailer in the U.S. with about 1,500 standalone stores. Their product range includes cosmetics, fragrances, skincare, and hair care, complemented by salon services. The company operates intensively in the U.S. marketplace while also making strides internationally, with acquisitions like Space NK and multiple franchise openings.

Understanding Ulta Beauty's Financial Framework

The company's financial indicators reflect remarkable performance:

Market Capitalization: Ulta boasts an impressive market cap, showcasing its solid footing in the beauty sector.

Revenue Growth: Over the last three months, Ulta has experienced a revenue growth rate of 9.26%, which outshines many competitors in the Consumer Discretionary sector.

Net Margin: Ulta's net margin stands at 9.36%, indicating strong profitability.

Return on Equity (ROE): The company's ROE is a commendable 10.36%, demonstrating good financial management.

Return on Assets (ROA): The ROA of 4.14% highlights the efficient utilization of assets to generate returns.

Debt Management: Ulta maintains a debt-to-equity ratio of 0.88, signifying a balanced approach towards financing.

Frequently Asked Questions

What earnings per share does Ulta Beauty expect to report?

Analysts anticipate Ulta Beauty will report an EPS of $4.58 in the upcoming earnings release.

How has Ulta's stock performed recently?

Ulta Beauty shares have seen a remarkable 40.05% increase in price over the past year, trading at $548.05.

What is the analyst consensus rating for Ulta Beauty?

The consensus rating for Ulta Beauty is Outperform, based on insights from several analysts.

How does Ulta Beauty compare to its industry peers?

Ulta leads in Revenue Growth and Gross Profit among its peers, ranking favorably in its industry.

What are Ulta Beauty's key financial metrics?

Ulta Beauty exhibits strong ROI metrics, with a net margin of 9.36%, 10.36% ROE, and a 4.14% ROA.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading

Top 5 Most Recently Viewed Articles

UK's Public Sector Deficit Grows Amid Rising Debt Concerns

Updated Category News Views 258

Understanding the Growing UK Budget Deficit The recent data revealed a significant increase in the UK’s budget deficit, raising concerns regarding the country's fiscal management. With borrowing hitting 17.8 billion pounds, which is approximately $21.93 billion in December, this figure surpassed previous expectations and highlighted the growing financial strain on the...

Continue Reading
Masimo Achieves New Stock Milestone with Exciting Growth

Updated Category News Views 151

Masimo Corporation Reaches New Heights in Stock Performance Masimo Corporation (NASDAQ: MASI), a leading global medical technology company, has made headlines by reaching a remarkable 52-week high, with its stock valued at an impressive $173.91. This notable achievement signifies a robust upward trend within the market, showcasing an extraordinary 1-year growth change of...

Continue Reading
Discover Cutting-Edge Coding Solutions at Pack Expo 2024

Updated Category News Views 77

Videojet Showcases Solutions at Pack Expo 2024 At Pack Expo 2024, Videojet Technologies, a leader in coding, marking, and printing solutions, will present an array of innovative products tailored to enhance the efficiency of packaging operations. This year's event will take place at McCormick Place, booth S-2030, from November 3 to 6. The company is eager to connect with...

Continue Reading
BioNTech Reaches $1.25 Billion Settlement Over Vaccine Royalties

Updated Category News Views 190

BioNTech's Settlements: A Closer Look BioNTech, the renowned German biotechnology firm known for its role in developing the COVID-19 vaccine alongside Pfizer, has recently made headlines with two significant settlement agreements. The company announced that it has entered into these agreements with the U.S. National Institutes of Health and the University of Pennsylvania...

Continue Reading
Rado's Anatom Collection: A Seasonal Revamp for Everyone

Updated Category News Views 138

A Fresh Evolution of Rado's Design Icon As the summer season approaches, Rado is thrilled to introduce three captivating new versions of its iconic Anatom timepiece. These refreshed models, available globally, embody a perfect blend of modern design and enduring craftsmanship. Originally launched in the early 80s, the Anatom timepiece was revolutionary, introducing...

Continue Reading